Therefore, β-blockers are able to inhibit development of pulmonary thrombo-embolism and SARS-CoV-2 infection-induced heart failure by inhibiting cyclophilin A-CD147 expression in the platelets and cardiomyocytes respectively with attenuation of neuroinflammation via inhibition of VEGF. This evidence concerns the gene PPIA and heart failure.